Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126083141 | 12608314 | 1 | I | 20160721 | 20160721 | 20160729 | 20160729 | EXP | DE-ACTELION-A-US2016-140132 | ACTELION | 0.00 | M | Y | 0.00000 | 20160729 | OT | DE | UY |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126083141 | 12608314 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK | U | U | 21779 | INHALATION VAPOUR, SOLUTION | |||||||
| 126083141 | 12608314 | 2 | SS | TRACLEER | BOSENTAN | 1 | Oral | U | U | 21290 | TABLET | ||||||||
| 126083141 | 12608314 | 3 | C | SILDENAFIL. | SILDENAFIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126083141 | 12608314 | 1 | Pulmonary hypertension |
| 126083141 | 12608314 | 2 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126083141 | 12608314 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126083141 | 12608314 | Headache | |
| 126083141 | 12608314 | Odynophagia | |
| 126083141 | 12608314 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126083141 | 12608314 | 1 | 20160721 | 0 |